June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Morphologic characteristics of a treatment poor-responsive fibrovascular pigment epithelium detachment type due to age-related macular degeneration
Author Affiliations & Notes
  • Florian Alten
    University Eye Hosp Muenster, Muenster, Germany
  • Christoph Roman Clemens
    University Eye Hosp Muenster, Muenster, Germany
  • Friederike Schubert
    University Eye Hosp Muenster, Muenster, Germany
  • Nicole Eter
    University Eye Hosp Muenster, Muenster, Germany
  • Footnotes
    Commercial Relationships Florian Alten, Bayer (R), Novartis (C); Christoph Clemens, Bayer (F), Novartis (F); Friederike Schubert, None; Nicole Eter, Allergan (C), Bayer (C), Heidelberg Engineering (C), Novartis (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5386. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Florian Alten, Christoph Roman Clemens, Friederike Schubert, Nicole Eter; Morphologic characteristics of a treatment poor-responsive fibrovascular pigment epithelium detachment type due to age-related macular degeneration . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5386.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Intravitreal anti-VEGF therapy has become a successful and established treatment strategy in neovascular age-related macular degeneration (AMD). However, it is known that some patients do not respond satisfactorily despite regular treatment. The aim of the study was to describe morphologic characteristics of poor-responsive fibrovascular pigment epithelium detachment (fPED) due to AMD.<br />

 
Methods
 

A retrospective study of 324 consecutive neovascular AMD patients was performed. All patients received three initial consecutive monthly intravitreal injections with ranibizumab or aflibercept and were controlled monthly thereafter and treated as needed. Spectral-domain optical coherence tomography (SD-OCT) was performed at all control visits. Fluorescein angiography (FA) was performed at baseline and if disease activity was questionable based on SD-OCT during follow-up. We included 45 patients with a fPED and a follow-up of 12 months. Morphologic poor response was defined as persistent subneurosensory fluid during follow-up visits.<br />

 
Results
 

22 (48.9%) of the included fPED patients showed a poor response to anti-VEGF therapy with a high number of injections (7.6/year). Mean visual acuity was 0.35 at baseline and 0.37 at 12-months follow-up. Development of geographic atrophy was present in no patient. 16 (72.7%) of the poor responsive fPED patients showed the following morphologic characteristics: A stippled hyperfluorescence followed by persistent staining within the retinal detachment in FA, an intact RPE band, an intact external limiting membrane, a recurrent subneurosensory slit of fluid and an increasingly hyperreflectivity filling the entire PED in SD-OCT scans.<br />

 
Conclusions
 

The described poor-responsive fPED type can be clearly set apart from a fibrotic lesion. Supposedly, morphologic changes seen in SD-OCT may be interpreted as maturization of CNV membrane including the ingrowth of pericytes which may cause poor-response to anti-VEGF therapy.<br />

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×